T. Rowe Price Associates
AGN

T. Rowe Price Associates’s Allergan plc AGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-721,666
Closed -$128M 2576
2020
Q1
$128M Sell
721,666
-1,698,878
-70% -$301M 0.02% 511
2019
Q4
$463M Sell
2,420,544
-746,736
-24% -$143M 0.06% 317
2019
Q3
$533M Buy
3,167,280
+368,679
+13% +$62M 0.08% 266
2019
Q2
$469M Buy
2,798,601
+463,755
+20% +$77.6M 0.07% 287
2019
Q1
$342M Buy
2,334,846
+520,129
+29% +$76.2M 0.05% 326
2018
Q4
$243M Sell
1,814,717
-177,272
-9% -$23.7M 0.04% 383
2018
Q3
$379M Sell
1,991,989
-330,754
-14% -$63M 0.06% 334
2018
Q2
$387M Sell
2,322,743
-11,565
-0.5% -$1.93M 0.06% 313
2018
Q1
$393M Sell
2,334,308
-252,091
-10% -$42.4M 0.06% 307
2017
Q4
$423M Sell
2,586,399
-1,487,656
-37% -$243M 0.07% 293
2017
Q3
$835M Sell
4,074,055
-1,416,979
-26% -$290M 0.14% 162
2017
Q2
$1.33B Sell
5,491,034
-3,147,687
-36% -$765M 0.24% 102
2017
Q1
$2.06B Sell
8,638,721
-660,408
-7% -$158M 0.39% 57
2016
Q4
$1.95B Sell
9,299,129
-3,433,124
-27% -$721M 0.39% 57
2016
Q3
$2.93B Sell
12,732,253
-3,858,522
-23% -$889M 0.59% 31
2016
Q2
$3.83B Sell
16,590,775
-4,475,883
-21% -$1.03B 0.81% 19
2016
Q1
$5.65B Sell
21,066,658
-627,360
-3% -$168M 1.21% 8
2015
Q4
$6.78B Sell
21,694,018
-819,704
-4% -$256M 1.43% 6
2015
Q3
$6.12B Buy
22,513,722
+846,972
+4% +$230M 1.36% 6
2015
Q2
$6.57B Buy
21,666,750
+1,892,527
+10% +$574M 1.35% 4
2015
Q1
$5.89B Buy
19,774,223
+9,136,305
+86% +$2.72B 1.22% 6
2014
Q4
$2.74B Buy
10,637,918
+6,638,874
+166% +$1.71B 0.58% 29
2014
Q3
$965M Buy
3,999,044
+1,297,402
+48% +$313M 0.21% 120
2014
Q2
$603M Buy
2,701,642
+133,507
+5% +$29.8M 0.13% 195
2014
Q1
$529M Buy
2,568,135
+1,014,414
+65% +$209M 0.12% 213
2013
Q4
$261M Buy
1,553,721
+111,912
+8% +$18.8M 0.06% 369
2013
Q3
$208M Buy
1,441,809
+783,578
+119% +$113M 0.05% 393
2013
Q2
$83.1M Buy
+658,231
New +$83.1M 0.02% 628